atai

Math Over Myth: ATAI & Cathie Wood’s Reverse Midas Touch

Math Over Myth: ATAI & Cathie Wood’s Reverse Midas Touch

This morning, ATAI Life Sciences (Nasdaq: ATAI) experienced a shocking drop of nearly 40% in its stock price, plummeting to an all-time low since the company’s June 2021 Initial Public Offering. The cause? A failed lead asset from its majority-owned Perception Neuroscience unit.

End of content

End of content